Abstract
Chimeric antigen receptor (CAR) T cell therapy has been a great success in CD19+ hematological diseases. Natural killer (NK) CAR cells offer an altern......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
